Trial Profile
The effect of Eldecalcitol for glucocorticoid induced osteoporosis patients who are not recommended bisphosphonates therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jul 2016
Price :
$35
*
At a glance
- Drugs Eldecalcitol (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 23 Jun 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 18 Jan 2013 New trial record